Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once- vs twice-daily insulin regimens with oral hypoglycaemic agents in type 2 diabetes
2005-003824-21Phase 4Terminated
- Sponsor
- Royal Liverpool University Hospital
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine, insulin detemir and biphasic insulin aspart in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Royal Liverpool University Hospital. Primary endpoint: HbA1c. Started May 2007; status: terminated.
02
Drugs
insulin glargineinsulin detemirbiphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-003824-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003824-21.